Welcome to YOSHIDA lab

Dr. Shigeto YOSHIDA has devoted years of study on the development of vaccines against infectious diseases, including malaria and COVID-19. We are actively working with other domestic and foreign groups toward this goal. The methodology is based on molecular cell biology and immunology. Students around the world are welcome to join YOSHIDA lab. If you speak English, Japanese-language skills are not always required. If you are interested in our projects, please feel free to contact us.

Recent publications

Antibodies

in press

Comparison between neutralization capacity of antibodies elicited by COVID-19 natural infection and vaccination in Indonesia: A prospective cohort

Nurisyah S, Iyori M, Hasyim AA, Sakamoto A, Hashimoto H, Yamagata K, Yamauchi S, Amru K, Zainal KH, Idris I, Yoshida S, Djaharuddin I, Syafruddin D, Bukhari A, Asih PBS, Yusuf Y

Parasitol Int

Feb, 2023

Adeno-associated virus-based malaria booster vaccine following attenuated replication-competent vaccinia virus LC16m8Δ priming

Hasyim AA, Iyori M, Mizuno T, Abe YI, Yamagoshi I, Yusuf Y, Syafira I, Sakamoto A, Yamamoto Y, Mizukami H, Shida H, Yoshida S

Emerg Microbes Infect

Dec, 2022

A replication-competent smallpox vaccine LC16m8Δ-based COVID-19 vaccine

Sakamoto A, Osawa H, Hashimoto H, Mizuno T, Hasyim AA, Abe YI, Okahashi Y, Ogawa R, Iyori M, Shida H, Yoshida S

Full publication list